Market closedNon-fractional

Bioventus/BVS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Bioventus

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Ticker

BVS

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Durham, United States

Employees

995

Bioventus Metrics

BasicAdvanced
$376M
Market cap
-
P/E ratio
-$0.34
EPS
0.63
Beta
-
Dividend rate
$376M
0.63
1.534
0.87
172.599
191.279
0.50%
1.52%
-11.87%
0.709
2.18
-1.22
181.169
1.72%
-92.58%
17.25%
47.18%

What the Analysts think about Bioventus

Analyst Ratings

Majority rating from 3 analysts.
Buy

Bioventus Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-3.47% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$129M
-4.43%
Net income
-$4.5M
-25.00%
Profit margin
-3.47%
-21.67%

Bioventus Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 193.33%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.14
$0.05
$0.07
$0.07
-
Expected
$0.00
-$0.02
$0.02
-$0.08
$0.07
Surprise
∞%
-350.00%
250.00%
-193.33%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Bioventus stock?

Bioventus (BVS) has a market cap of $376M as of July 06, 2024.

What is the P/E ratio for Bioventus stock?

The price to earnings (P/E) ratio for Bioventus (BVS) stock is 0 as of July 06, 2024.

Does Bioventus stock pay dividends?

No, Bioventus (BVS) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Bioventus dividend payment date?

Bioventus (BVS) stock does not pay dividends to its shareholders.

What is the beta indicator for Bioventus?

Bioventus (BVS) has a beta rating of 0.63. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Bioventus stock

Buy or sell Bioventus stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing